Narayana Hrudayalaya Latest Share Price (NH)
TODAY IN ONE LINE
NH slipped 0.9% on above-average volume (2.4x avg), in line with Nifty's 0.1% move, supported by recent strong earnings.
With a market cap of ₹38,460.7 Cr., it trades at a P/E of 47.95. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Narayana Hrudayalaya flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 13.5% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 75.8% and Profit up 12.5%
- ●High Capital EfficiencyROCE of 15.4% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 20.9%
- ●Healthy Operating MarginsOPM is structurally strong at 20.4%
- ●High Promoter HoldingPromoters hold 63.3% skin-in-the-game
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Rising Receivables vs SalesReceivables grew 31.0% outpacing sales growth of 12.1%
Latest Narayana Hrudayalaya News
What changed recently?
Recent events, corporate actions, and announcements.
Narayana Hrudayalaya Ltd. valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Narayana Hrudayalaya Ltd., framed against the sector median so the premium or discount is obvious at a glance.
Narayana Hrudayalaya Ltd. trades at a P/E of 47.95× and P/B of 8.63×, against the Healthcare sector median P/E of 46.27×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Narayana Hrudayalaya Ltd. technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Narayana Hrudayalaya Ltd. — derived from the latest tape, not yesterday's close.
Narayana Hrudayalaya Ltd. last traded at ₹1,885 with an intraday range of ₹1,877.1–₹1,913.4 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹1885.00| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1979.17 | +94.17 | +5.00% |
| R3 | 1942.87 | +57.87 | +3.07% |
| R2 | 1928.13 | +43.13 | +2.29% |
| R1 | 1906.57 | +21.57 | +1.14% |
| PIVOT | 1891.83 | 6.83 | 0.36% |
| CURRENT | 1885.00 | — | — |
| S1 | 1870.27 | -14.73 | -0.78% |
| S2 | 1855.53 | -29.47 | -1.56% |
| S3 | 1833.97 | -51.03 | -2.71% |
| S4 | 1797.67 | -87.33 | -4.63% |
NH is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹1897.3–₹1913.4
Trading Below opening range, showing Bearishness
Narayana Hrudayalaya Ltd. financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Narayana Hrudayalaya Ltd. — consolidated or standalone — with margins, YoY growth and key ratios inline.
Narayana Hrudayalaya Ltd. reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹38,460.7 Cr. and reported EPS of ₹39.97.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 5,483 | 7,896 ▲ 44.0% |
| Sales Growth YoY %Derived | 9.26% | 44.01% |
| Other Income | 92 | 100 ▲ 8.9% |
| Total Income | 5,575 | 7,996 ▲ 43.4% |
| 1,136 | 1,516 ▲ 33.4% | |
| Gross ProfitDerived | 4,347 | 6,380 ▲ 46.8% |
| Gross Margin %Derived | 79.27% | 80.80% |
| 3,070 | 4,763 ▲ 55.1% | |
| EBITDA (Operating Profit)Derived | 1,276 | 1,617 ▲ 26.7% |
| OPM %Derived | 23.28% | 20.47% |
| 416 | 641 ▲ 53.9% | |
| Profit Before Tax (PBT) | 936 | 974 ▲ 4.2% |
| 146 | 158 ▲ 8.7% | |
| Effective Tax %Derived | 15.58% | 16.25% |
| Profit/Loss from Discontinued Ops | 1 | -4 ▼ 651.7% |
| Total Profit for Period | 791 | 806 ▲ 1.9% |
| Less: Non-controlling Interests | 0 | 0 ▼ 20.2% |
| Net Profit (Owner's PAT)Derived | 790 | 806 ▲ 2.0% |
| Net Profit Margin %Derived | 14.41% | 10.20% |
| PAT Growth YoY %Derived | 0.11% | 1.95% |
| Earnings Per Share (EPS ₹) | 38.66 | 39.42 ▲ 2.0% |
| Diluted Shares Outstanding (Cr) | 20 | 20 ▲ 0.0% |
| Share of Profit from Associates/JVs | — | — |
| Other Comprehensive Income (Net of Tax) | 34 | 197 ▲ 482.8% |
| Total Expenses (incl. D&A & Interest) | 4,639 | 7,022 ▲ 51.4% |
| Material Cost % of RevenueDerived | — | — |
| Employee Cost % of RevenueDerived | 19.93% | 22.83% |
| Other Cost % of RevenueDerived | 36.07% | 37.49% |
| Interest Coverage (x)Derived | 6.82x | 4.80x |
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 2,281 | 2,861 ▲ 25.4% | 3,128 ▲ 9.3% | 2,582 ▼ 17.4% | 3,701 ▲ 43.3% | 4,525 ▲ 22.2% | 5,018 ▲ 10.9% | 5,483 ▲ 9.3% | 7,896 ▲ 44.0% | |
| Sales Growth YoY %Derived | — | 25.43% | 9.33% | -17.44% | 43.33% | 22.25% | 10.91% | 9.26% | 44.01% | |
| Other Income | 19 | 17 ▼ 11.8% | 24 ▲ 42.5% | 28 ▲ 18.6% | 35 ▲ 22.7% | 65 ▲ 89.4% | 75 ▲ 14.9% | 92 ▲ 22.4% | 100 ▲ 8.9% | |
| Total Income | 2,300 | 2,878 ▲ 25.1% | 3,152 ▲ 9.5% | 2,611 ▼ 17.2% | 3,736 ▲ 43.1% | 4,590 ▲ 22.9% | 5,093 ▲ 11.0% | 5,575 ▲ 9.5% | 7,996 ▲ 43.4% | |
557 | 688 ▲ 23.5% | 745 ▲ 8.4% | 678 ▼ 9.1% | 909 ▲ 34.1% | 1,001 ▲ 10.1% | 1,074 ▲ 7.3% | 1,136 ▲ 5.8% | 1,516 ▲ 33.4% | ||
| Gross ProfitDerived | 1,724 | 2,173 ▲ 26.0% | 2,382 ▲ 9.6% | 1,904 ▼ 20.1% | 2,792 ▲ 46.6% | 3,524 ▲ 26.2% | 3,944 ▲ 11.9% | 4,347 ▲ 10.2% | 6,380 ▲ 46.8% | |
| Gross Margin %Derived | 75.60% | 75.97% | 76.17% | 73.75% | 75.44% | 77.87% | 78.60% | 79.27% | 80.80% | |
1,512 | 1,886 ▲ 24.7% | 1,960 ▲ 3.9% | 1,722 ▼ 12.1% | 2,139 ▲ 24.2% | 2,558 ▲ 19.6% | 2,792 ▲ 9.2% | 3,070 ▲ 10.0% | 4,763 ▲ 55.1% | ||
| EBITDA (Operating Profit)Derived | 212 | 288 ▲ 35.6% | 423 ▲ 46.9% | 182 ▼ 56.9% | 654 ▲ 258.9% | 966 ▲ 47.8% | 1,152 ▲ 19.3% | 1,276 ▲ 10.8% | 1,617 ▲ 26.7% | |
| OPM %Derived | 9.31% | 10.06% | 13.52% | 7.05% | 17.66% | 21.35% | 22.96% | 23.28% | 20.47% | |
147 | 209 ▲ 41.8% | 260 ▲ 24.6% | 253 ▼ 2.9% | 241 ▼ 4.5% | 279 ▲ 15.8% | 339 ▲ 21.4% | 416 ▲ 22.8% | 641 ▲ 53.9% | ||
| Profit Before Tax (PBT) | 85 | 96 ▲ 12.6% | 165 ▲ 72.1% | -56 ▼ 134.0% | 430 ▲ 866.5% | 752 ▲ 74.9% | 889 ▲ 18.2% | 936 ▲ 5.3% | 974 ▲ 4.2% | |
29 | 34 ▲ 17.8% | 42 ▲ 23.8% | -42 ▼ 198.9% | 88 ▲ 309.8% | 145 ▲ 65.4% | 99 ▼ 31.8% | 146 ▲ 47.3% | 158 ▲ 8.7% | ||
| Effective Tax %Derived | 34.07% | 35.64% | 25.65% | 74.51% | 20.40% | 19.29% | 11.13% | 15.58% | 16.25% | |
| Profit/Loss from Discontinued Ops | — | — | — | — | — | — | — | 1 | -4 ▼ 651.7% | |
| Total Profit for Period | 51 | 59 ▲ 15.3% | 119 ▲ 100.8% | -14 ▼ 112.0% | 342 ▲ 2493.5% | 607 ▲ 77.3% | 790 ▲ 30.2% | 791 ▲ 0.1% | 806 ▲ 1.9% | |
| Less: Non-controlling Interests | 0 | 0 ▲ 96.4% | 0 ▲ 25.9% | 0 ▼ 92.6% | 0 ▲ 1790.0% | 0 ▲ 68.3% | 0 ▲ 13.8% | 0 ▲ 31.5% | 0 ▼ 20.2% | |
| Net Profit (Owner's PAT)Derived | 51 | 59 ▲ 15.2% | 119 ▲ 101.0% | -14 ▼ 112.0% | 342 ▲ 2490.5% | 606 ▲ 77.3% | 789 ▲ 30.2% | 790 ▲ 0.1% | 806 ▲ 2.0% | |
| Net Profit Margin %Derived | 2.25% | 2.07% | 3.80% | -0.55% | 9.24% | 13.40% | 15.73% | 14.41% | 10.20% | |
| PAT Growth YoY %Derived | — | 15.23% | 100.98% | -112.03% | 2,490.46% | 77.30% | 30.19% | 0.11% | 1.95% | |
| Earnings Per Share (EPS ₹) | 2.51 | 2.90 ▲ 15.5% | 5.82 ▲ 100.7% | -0.70 ▼ 112.0% | 16.73 ▲ 2490.0% | 29.67 ▲ 77.3% | 38.62 ▲ 30.2% | 38.66 ▲ 0.1% | 39.42 ▲ 2.0% | |
| Diluted Shares Outstanding (Cr) | 20 | 20 ▲ 0.0% | 20 ▲ 0.0% | 20 ▲ 0.0% | 20 ▲ 0.0% | 20 ▲ 0.0% | 20 ▲ 0.0% | 20 ▲ 0.0% | 20 ▲ 0.0% | |
| Share of Profit from Associates/JVs | -5 | -2 ▲ 49.6% | -3 ▼ 47.0% | — ▲ 100.0% | — | — | — | — | — | |
| Other Comprehensive Income (Net of Tax) | 3 | -0 ▼ 111.9% | 5 ▲ 1225.1% | -2 ▼ 143.3% | 26 ▲ 1396.6% | 57 ▲ 116.7% | 14 ▼ 75.7% | 34 ▲ 145.1% | 197 ▲ 482.8% | |
| Total Expenses (incl. D&A & Interest) | 2,215 | 2,782 ▲ 25.6% | 2,987 ▲ 7.4% | 2,667 ▼ 10.7% | 3,306 ▲ 24.0% | 3,839 ▲ 16.1% | 4,205 ▲ 9.5% | 4,639 ▲ 10.3% | 7,022 ▲ 51.4% | |
| Material Cost % of RevenueDerived | — | — | — | — | — | — | — | — | — | |
| Employee Cost % of RevenueDerived | 20.42% | 21.81% | 21.54% | 24.29% | 20.76% | 19.43% | 20.01% | 19.93% | 22.83% | |
| Other Cost % of RevenueDerived | 45.88% | 44.09% | 41.11% | 42.41% | 37.02% | 37.10% | 35.62% | 36.07% | 37.49% | |
| Interest Coverage (x)Derived | 2.40x | 2.11x | 2.78x | -0.02x | 7.09x | 10.88x | 9.40x | 6.82x | 4.80x |
Narayana Hrudayalaya segment analysis : revenue and profit mix.
Disclosed business segments at Narayana Hrudayalaya with their share of revenue and profit, switchable between consolidated and standalone reporting.
Narayana Hrudayalaya discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Narayana Hrudayalaya Ltd..
Our AI distills the core fundamental drivers supporting Narayana Hrudayalaya Ltd., the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Narayana Hrudayalaya Ltd.'s investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
ROE 20.90% and ROCE 15.40% exceed sector benchmarks, demonstrating superior capital efficiency.
Operating margin 14.80% (annual) ranks highest among peers, signaling robust pricing power.
TTM revenue growth 75.80% YoY vastly outpaces competitors, indicating strong market share capture.
Promoter holding 63.27% ensures stable governance and long-term strategic alignment with shareholders.
Latest quarterly EPS grew 13.50% YoY, reflecting earnings resilience despite modest profit variance.
Key Risks.
Latest quarterly profit declined 2.26% YoY despite revenue growth, signaling emerging margin compression.
Net cash flow negative ₹420.88 Cr (H1 FY26), raising concerns about liquidity and cash management.
Dividend yield 0.23% minimal, limiting income appeal for yield-focused and conservative investors.
Free cash flow negative ₹206.62 Cr (FY26) due to capex ₹965.19 Cr strains reinvestment flexibility.
P/E ratio 49.69x elevated relative to near-term earnings visibility and historical growth rates.
Flip Conditions.
Valuation risk. a P/E above 62 (~1.3× the sector multiple of 46.3) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.79. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 16% would indicate weaker capital compounding.
Narayana Hrudayalaya Ltd. peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Narayana Hrudayalaya Ltd. is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Narayana Hrudayalaya Ltd. chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Narayana Hrudayalaya Ltd. — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Narayana Hrudayalaya Ltd. delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Narayana Hrudayalaya Ltd. over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Narayana Hrudayalaya Ltd. stood at 86.0% of traded volume, against a 20-day average of 58.7%.
Narayana Hrudayalaya announcements: results, concalls, ratings, M&A.
Filings Narayana Hrudayalaya sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Narayana Hrudayalaya files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 166 documents below.
Press Release
Narayana Hrudayalaya Ltd. has informed the Exchange regarding a press release dated July 31, 2026, titled "PRESS RELEASE Q1 FY27 Results".
Investor Presentation
Narayana Hrudayalaya Ltd. has informed the Exchange about Investor Presentation
Outcome of Board Meeting
Narayana Hrudayalaya Ltd. has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Updates
Narayana Hrudayalaya Ltd. has informed the Exchange regarding disptach of Letter to Shareholders regarding Weblink of 26th AGM Notice and Annual…
Analysts/Institutional Investor Meet/Con. Call Updates
Narayana Hrudayalaya Ltd. has informed the Exchange that the management of the company will host a conference call to discuss the company's…
Investor decks & rating reports.
Narayana Hrudayalaya dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Narayana Hrudayalaya has declared, sequenced by announce and record date.
Narayana Hrudayalaya corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Narayana Hrudayalaya Ltd.: business, sector, key facts.
What Narayana Hrudayalaya Ltd. does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Narayana Hrudayalaya Ltd. operates in the Hospital industry under the Healthcare sector, listed as NSE: NH, BSE: 539551.
Narayana Hrudayalaya Limited (NH) is a major player in the Indian healthcare sector, with a global reach. Its core business revolves around providing a wide range of medical and healthcare services. This includes the ownership and operation of a network of hospitals, clinics, diagnostic centers, and other healthcare facilities. NH's extensive network allows it to serve a substantial patient population across diverse geographical locations.
The company's service offerings are comprehensive, spanning a vast spectrum of medical specialties. These include cardiology and cardiac surgery, representing a significant area of focus, alongside nephrology, urology, neurology, neurosurgery, endocrinology, orthopedics, internal medicine, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology. This breadth of services allows NH to cater to a diverse range of patient needs and health conditions.
NH operates through two primary segments: Medical and Healthcare Related Services, and Others. The "Medical and Healthcare Related Services" segment encompasses the core operations of providing direct patient care across its numerous facilities. The "Others" segment likely includes supporting business activities, which may involve ancillary services, administrative functions, or other revenue streams outside of direct medical provision. The specific nature of the "Others" segment isn't detailed in the provided source.
Beyond direct patient care, NH also has a presence in the health insurance sector. This diversification allows the company to engage in a broader range of healthcare-related activities, potentially offering integrated solutions for patients and further strengthening its position within the market. This vertical integration likely contributes to a more robust and resilient business model.
Established in 2000 and headquartered in Bengaluru, India, NH has grown significantly over the years, establishing itself as a prominent healthcare provider in India and expanding internationally. Its continued growth and success are built upon a foundation of delivering comprehensive medical services across a wide range of specialties, complemented by its diversification into health insurance.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Dr Agarwal's Health Care (AGARWALEYE) Share PricePeer
- Apollo Hospitals Enterprise (APOLLOHOSP) Share PricePeer
- Artemis Medicare Services (ARTEMISMED) Share PricePeer
- Aster DM Healthcare (ASTERDM) Share PricePeer
- Fortis Healthcare (FORTIS) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Narayana Hrudayalaya Ltd. (NH).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Narayana Hrudayalaya Ltd. (NH)?
The current share price of Narayana Hrudayalaya Ltd. (NH) is ₹1,885.00. Today, the stock has declined by ₹18.10 (0.95%), trading in a range of ₹1,877.10 to ₹1,913.40. The stock opened at ₹1,912.50 with a trading volume of 7,03,113 shares.
02Is Narayana Hrudayalaya Ltd. stock a good investment for long-term?
Narayana Hrudayalaya Ltd. can be considered for long-term investment based on several factors. The company has a market capitalization of ₹38,460.7 Cr., P/E ratio of 47.95, ROE of 20.9%, and ROCE of 15.4%. The dividend yield stands at 0.23%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Narayana Hrudayalaya Ltd. stock?
The 52-week high price of Narayana Hrudayalaya Ltd. (NH) is ₹2,093.30, while the 52-week low is ₹1,589.00. Currently trading at ₹1,885.00, the stock is 18.63% above its 52-week low and 9.95% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Narayana Hrudayalaya Ltd. stock at the current price?
Whether to buy Narayana Hrudayalaya Ltd. stock at ₹1,885.00 depends on multiple factors. The stock is currently trading with a P/E ratio of 47.95 and P/B ratio of 8.63. Today's performance shows a loss of 0.95%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Narayana Hrudayalaya Ltd. and when is the next dividend?
Narayana Hrudayalaya Ltd. offers a dividend yield of 0.23%, which means for every ₹100 invested at the current price of ₹1,885.00, you can expect to receive approximately ₹0.23 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Narayana Hrudayalaya Ltd.?
Narayana Hrudayalaya Ltd.'s key financial metrics include: P/E Ratio: 47.95, P/B Ratio: 8.63, ROE: 20.9%, ROCE: 15.4%, Dividend Yield: 0.23%, EPS: ₹39.97, Book Value: ₹223.34, and Debt-to-Equity: 1.29. The company's market cap stands at ₹38,460.7 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Narayana Hrudayalaya Ltd. stock performing today in the market?
Narayana Hrudayalaya Ltd. stock opened at ₹1,912.50 and is currently trading at ₹1,885.00, showing a decline of ₹18.10 (0.95%). The intraday high is ₹1,913.40 and low is ₹1,877.10. The trading volume stands at 7,03,113 shares, indicating moderate market participation today.
08What is the P/E ratio of Narayana Hrudayalaya Ltd. and what does it indicate?
Narayana Hrudayalaya Ltd. has a Price-to-Earnings (P/E) ratio of 47.95, which means investors are willing to pay 47.95 for every ₹1 of earnings. With an EPS of ₹39.97, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Narayana Hrudayalaya Ltd. (NH) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.